register  quick_nav_bullet contact us  quick_nav_bullet about CBI  quick_nav_bullet IVT  quick_nav_bullet 1.800.817.8601  quick_nav_bullet
CBI Logo  
Conferences Web Seminars Sponsorship Marketing Opportunities Other Services Purchase CD-ROM About CBI
  About CBI
  Company Profile
  News & Press Releases
  Registration FAQs
  Press Pass FAQs
  Accreditation
  Careers
  Speaking Opportunities
  Elite Speaker Faculty
  Directions
  Contact Us

In the News

PHARMACEUTICAL COMPANIES
SHOULD MAKE GRANT PROCESS TRANSPARENT


In theory, creating a grant strategy is easy, but not in practice, said Belinda Hunt, PhD, associate director of medical education and grants at Biogen Idec in Wellesley, MA.

Hunt, speaking on a panel during the Center for Business Intelligence’s Sixth Annual Pharmaceutical Compliance Congress in Washington D.C. January 27, said companies should first set up a grant committee to evaluate each grant application. The authority to approve grants can reside in the medical affairs, legal, or compliance department, but should not be in the sales and marketing department.

Continue reading for more about the grant process.

 
Testimonials
“This conference was informative and encouraging, affording the opportunity to learn and collaborate across companies. We are all truthfully in this together!”
– Heather Ferrence, Supervisor Product Quality, Wyeth

“Being in transition for employment, this was critical to come to CBI to network and to also keep my edge in the industry”
– Ramie Zomisky

“Excellent; Actionable nuggets to take back and implement”
– Kay Rayner Curling, Director, Work Life Solutions, SRA International

 
 
 
 
 
home | contact us | about CBI | privacy policy
© 2010 The Center for Business Intelligence